Give you a statement and table with its title in Markdown format, please determine whether the statement is supported or refuted by, or is unrelated to the table. It'a binary classification problem, you should choose the answer between supported and refuted. Table cells in one row are seperated by '|', and different rows are seperated by '
'.

Table:
| antibody | brand name | approval date | type | target | approved treatment (s) |
| alemtuzumab | campath | 2001 | humanized | cd52 | chronic lymphocytic leukemia |
| bevacizumab | avastin | 2004 | humanized | vascular endothelial growth factor | colorectal cancer |
| brentuximab vedotin | adcetris | 2011 | chimeric | cd30 | hodgkin lymphoma , anaplastic large - cell lymphoma |
| cetuximab | erbitux | 2004 | chimeric | epidermal growth factor receptor | colorectal cancer |
| gemtuzumab ozogamicin | mylotarg | 2000 | humanized | cd33 | acute myelogenous leukemia (with calicheamicin ) |
| panitumumab | vectibix | 2006 | human | epidermal growth factor receptor | colorectal cancer |
| rituximab | rituxan , mabthera | 1997 | chimeric | cd20 | non - hodgkin lymphoma |
Title:
cancer immunotherapy
Statement:
the target cd30 is approved to treat both hodgkin lymphoma and anaplastic large - cell lymphoma
Answer:
supported